Literature DB >> 8974823

Transesophageal echocardiography-guided transvenous endomyocardial biopsy used to diagnose primary cardiac angiosarcoma.

A J Hammoudeh1, F Chaaban, R M Watson, A Millman.   

Abstract

Primary cardiac tumors are rare clinical entities with the histologic diagnosis usually made from surgically obtained tissue or at postmortem examination. Transvenous endomyocardial biopsy has been used less frequently, under fluoroscopic or transthoracic echocardiographic guidance. In this case report, we utilized the transesophageal echocardiography to guide the endomyocardial biopsy from a right atrial tumor in a 35-year-old man.

Entities:  

Mesh:

Year:  1996        PMID: 8974823     DOI: 10.1002/(SICI)1097-0304(199603)37:3<347::AID-CCD30>3.0.CO;2-C

Source DB:  PubMed          Journal:  Cathet Cardiovasc Diagn        ISSN: 0098-6569


  4 in total

1.  Successful surgical excision of primary right atrial angiosarcoma.

Authors:  Wobbe Bouma; Chris P H Lexis; Tineke P Willems; Albert J H Suurmeijer; Iwan C C van der Horst; Tjark Ebels; Massimo A Mariani
Journal:  J Cardiothorac Surg       Date:  2011-04-09       Impact factor: 1.637

2.  Rapidly progressive respiratory failure with multiple halo signs on computed tomography in a patient with primary cardiac angiosarcoma derived from the right atrium: a case report.

Authors:  Masaoki Saito; Takeshi Saraya; Miku Oda; Toshinori Minamishima; Ken Kongoji; Aya Isomura; Masachika Fujiwara; Kyoko Soejima; Haruyuki Ishii
Journal:  BMC Pulm Med       Date:  2020-12-09       Impact factor: 3.317

3.  Right atrium angiosarcoma with feeding vessels from right coronary artery: a case report.

Authors:  Jian-Kuan Yeh; Yi-Shan Tsai; Ya-Ping Chen; Jun-Neng Roan; Hsien-Yuan Chang
Journal:  Eur Heart J Case Rep       Date:  2022-01-18

Review 4.  Percutaneous intravenous catheter forceps biopsy in right atrial mass: two case reports and literature review.

Authors:  Lei Chang; Chenyi Gong; Haitao Lu; Yihai Liu; Lina Kang; Jianzhou Chen; Lian Wang; Biao Xu
Journal:  BMC Cardiovasc Disord       Date:  2022-02-20       Impact factor: 2.298

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.